Radiance Therapeutics, Inc. — Form D/A
Radiance Therapeutics, Inc. of TUCSON, AZ, a company, filed a Form D amendment with the SEC on 2023-06-29. The offering totals $10.5M, of which $9.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-06-29
- Form: D/A
- Accession: 0001742457-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $10.5M
- Amount sold: $9.0M
- Remaining: $1.5M
- Minimum investment: $1K
- Investors: 51
- Date of first sale: 2020-12-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-384512
Issuer
- Name: Radiance Therapeutics, Inc.
- CIK: 0001742457
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 7440 N. ORACLE ROAD, BLDG. 1, TUCSON, AZ, 85704
- Phone: 520-582-0960
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Ken John Abrahams | Director | Tucson, AZ |
| Peng John Khaw | Director | Tucson, AZ |
| Laurence John Marsteller | Director | Tucson, AZ |
| Marc John Sandroff | Director | Tucson, AZ |
| Laurence John Marsteller | Executive Officer | Tucson, AZ |
| G. Todd John Silva | Executive Officer | Tucson, AZ |
| Harry Allan George | Director | Tucson, AZ |
| Harry Allan George | Executive Officer | Tucson, AZ |
Other filings by this issuer (7)
More